SRZN - Surrozen, Inc./DE
27.74
0.340 1.226%
Share volume: 101,232
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$27.40
0.34
0.01%
Summary score
35%
Profitability
35%
Dept financing
42%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-40.44%
Return on sales
-688.87%
Return on invested capital
0%
Total debt ratio
82.55%
Debt ratio change over timeo
0%
Current Ratio
8.54%
Quick Ratio
0%
Cash Position Ratio
7.57%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-58.05%
Return on sales
-1039.47%
Return on invested capital
0%
Total debt ratio
110.03%
Debt ratio change over timeo
0%
Current Ratio
11.59%
Quick Ratio
0%
Cash Position Ratio
11.03%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-77.15%
Return on sales
-1107.32%
Return on invested capital
0%
Total debt ratio
125%
Debt ratio change over time
0%
Current Ratio
13.15%
Quick Ratio
0%
Cash Position Ratio
12.46%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SRZN | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 28.34% | 5.51% | 6.15% |
| Return on assets | -40.44% | 3.06% | 3.18% | 2.21% |
| Return on sales | -688.87% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | 0% | 6.42% | 3.22% | 6.7% |
| Profitability | 0% | 98% | 66% | 68% |
| Total debt ratio | 82.55% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | 0% | 12.76% | 169.64% | 13.01% |
| Dept financing | 22% | 27% | 43% | 14% |
| Current Ratio | 11.59% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 11.03% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 28% | 23% | 34% |
| Short-term ratios | SRZN | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -58.05% | 3.09% | 4.74% | 1.98% |
| Return on sales | -1039.47% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 33% | 50% | 26% |
| Total debt ratio | 110.03% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 21% | 15% | 9% |
| Current Ratio | 11.59% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 11.03% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 20% | 27% | 31% |